EMBO Molecular Medicine · 2016 · 83 citations · 40 references
Life SciencesCardiologyMolecular BiologyGene ExpressionInflammationPreventive CardiologyCardiovascular DiseaseExtracellular Matrix RemodelingMicrorna BiologyMicrorna-mediated RegulationPlaque ControlTissue RemodelingAtherosclerotic ProgressionExtracellular Matrix SignalingFibrous Cap ThicknessLesion Size ReductionMicrorna TherapeuticsMicrorna TherapyPlaque StabilityPlaque Stabilization
Abnormal remodeling of atherosclerotic plaques can lead to rupture, acute myocardial infarction, and death. Enhancement of plaque extracellular matrix (ECM) may improve plaque morphology and stabilize lesions. Here, we demonstrate that chronic administration of LNA-miR-29 into an atherosclerotic mouse model improves indices of plaque morphology. This occurs due to upregulation of miR-29 target genes of the ECM (col1A and col3A) resulting in reduced lesion size, enhanced fibrous cap thickness, and reduced necrotic zones. Sustained LNA-miR-29 treatment did not affect circulating lipids, blood chemistry, or ECM of solid organs including liver, lung, kidney, spleen, or heart. Collectively, these data support the idea that antagonizing miR-29 may promote beneficial plaque remodeling as an independent approach to stabilize vulnerable atherosclerotic lesions.
40
The functions of animal microRNAs
Victor Ambros · Nature · 2004 · 10.8K citations
Forecasting the Future of Cardiovascular Disease in the United States
Paul A. Heidenreich, Justin G. Trogdon, Olga Khavjou et al. · Circulation · 2011 · 3.2K citations · Full text
Zorina S. Galis, Galina K. Sukhova, Michael W. Lark et al. · Journal of Clinical Investigation · 1994 · 2.5K citations · Full text